Why a new vaginal ring could be a game-changer in HIV prevention
The quest for the (vaginal) ring – The Mail & Guardian
IPM's dapivirine ring could be the future of female-first HIV prevention
Dapivirine vaginal ring use during pregnancy's third trimester poses no safety concerns: Study
Ring-ing in the Future: Participant and Male Partner Perspectives Regarding Future Use of the Dapivirine Vaginal Ring for HIV Prevention | SpringerLink
Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study - The Lancet HIV
Vaginal Ring Provides Partial Protection From HIV in Large Multinational Trial
The Dapivirine Vaginal Ring - PrEPWatch
WHO Recommends Dapivirine Ring for HIV Prevention, but Not Alone - POZ
Dapivirine Ring Appears Safe for HIV Prevention While Breastfeeding - Pharmacy Practice News
InfoNile on Twitter: "Edit Tweet: The dapivirine ring reduces HIV/AIDS contraction by 50%. In 2018 , there were 800,000 HIV cases in Sub-Saharan Africa; of those, 208,000 were women between 15-24 years (
Vaginal Ring Offers Hope in HIV Prevention - Scientific American
IPM's dapivirine ring for women's HIV prevent | EurekAlert!
Dapivirine Ring - Wikipedia
Virtual CROI 2022: The dapivirine ring vs. the FDA | Positively Aware
UNAIDS is hopeful that a new long-acting HIV prevention option will soon become available for women in sub-Saharan Africa | UNAIDS
EMA adopts first-ever vaginal ring for HIV prevention | Aidsfonds.org
High uptake and use of vaginal ring for HIV prevention observed in open-label study | National Institutes of Health (NIH)
_small.jpg?sfvrsn=d564fe71_7 "WHO continues to support its conditional recommendation for the dapivirine vaginal ring as an additional prevention option for women at substantial risk of HIV")
WHO continues to support its conditional recommendation for the dapivirine vaginal ring as an additional prevention option for women at substantial risk of HIV
Three-month Dapivirine Ring | International Partnership For Microbicides
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women | NEJM
